BioSpace News Archive

UNAHCO seeks to expand use of OxC-BetaTM Livestock with new application in Broilers, creating new market opportunity for expanded use in a wide variety of feeds worldwide

Enrollment completed in SAGE-217 Phase 3 MOUNTAIN and SHORELINE studies with topline data expected in 4Q 2019 and 2020, respectively

Based on these positive results, Lilly has submitted for U.S. regulatory approval for adults with active non-radiographic axial spondyloarthritis

Eagle expects to file a supplement to the current NDA for the treatment of brain damage secondary to nerve agent exposure in the second half of 2020

Neon Therapeutics, Inc., a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, reported financial results for the third quarter ended September 30, 2019 and provided a business update.

BrainStorm Cell Therapeutics, Inc., a leading developer of adult stem cell therapies for neurodegenerative diseases, announced that the Company’s Chief Operating and Chief Medical Officer Ralph Kern MD MHSc will present at the 7th International Stem Cell Meeting, which is hosted by the Israel Stem Cell Society.

Kodiak Sciences Inc., a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, reported business highlights and financial results for the third quarter ended September 30, 2019.

TCR2 Therapeutics Inc., a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, announced financial results for the third quarter ended September 30, 2019 and provided a corporate update.

Data presented by MD Anderson demonstrates superiority for NBTXR3 activated by radiation therapy and anti-PD-1 in combination versus the radiation therapy and anti-PD-1 combination in an in vivo anti-PD-1-resistant model

MediPharm Labs Corp. a global leader in specialized, research-driven cannabis extraction, distillation and purification, announced its financial results for the three and nine months ended September 30, 2019.